Dedicated to a Safer World
Dedicated to developing novel medical solutions to protect Americans at home and on the battlefield.
January 19, 2017
PharmAthene and Altimmune Announce Merger to Create Immunotherapeutics Company Ta...
November 17, 2016
PharmAthene Declares $2.91 Special Cash Dividend on Common Stock
November 16, 2016
PharmAthene Receives Final Payment from SIGA of $83.9 Million
November 04, 2016
PharmAthene Reports Third Quarter 2016 Financial and Operational Results
PharmAthene Adopts Stockholder Rights Plan